ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1840

Synovial Resident Memory T Cell Formation During Inflammation Requires Cell Contact with Fibroblast-Like Synoviocytes

Yusuke Miyashita1, Yang Yang1, Madison Mangin1, Maryrose Hahn2, Kevin Wei3, Peter Nigrovic4 and Margaret Chang1, 1Boston Children's Hospital, Boston, MA, 2Boston Children's Hospital, Georgetown, MA, 3Brigham and Women's Hospital at Harvard Medical School, Boston, MA, 4Boston Children's Hospital, Brookline, MA

Meeting: ACR Convergence 2024

Keywords: Fibroblasts, Synovial, rheumatoid arthritis, Synovitis, T Cell, Tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: T Cell Biology & Targets in Autoimmune & Inflammatory Disease Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by recurrent inflammation in the same joints, a feature termed joint-specific memory. We previously demonstrated that joint-specific memory in arthritis is mediated by resident memory T (TRM) cells in the synovium. TRM cells are present in the synovium of previously inflamed joints and antigen-specific activation of TRM cells can drive recurrent arthritis flare. In evaluating the mediators of TRM cell development in the joint, we have previously shown that TNF can induce TRM cell formation in synovial organoids. Here, we investigated the roles of both fibroblasts and T cells in TNF stimulation promoting TRM cell formation.

Methods: CD8 memory T cells were isolated from peripheral blood mononuclear cells of healthy donors and fibroblast-like synoviocytes (FLS) were isolated from the synovium of rheumatoid arthritis patients (RA-FLS). To determine if TRM cell formation is mediated by RA-FLS, we generated 3D synovial organoids with T cells and RA-FLS encapsulated in Matrigel, with or without human umbilical vein endothelial cells (HUVEC) and assessed for TRM cell formation 3 weeks later. To assess the respective roles of T cells and RA-FLS in TNF-driven TRM cell formation, T cells and RA-FLS were stimulated with TNF independently for 3 days before TNF was removed, and then the two cell types were cultured together for 14 days. As controls, cells were either left unstimulated or stimulated together in the same well. Transwells with 5.0µm pore size were utilized to spatially separate T cells and RA-FLS to assess for the necessity of cell contact. Flow cytometric analysis was performed after 14 days in culture to evaluate for the presence of TRM cells and markers of T cell activation.

Results: TRM cells can form in a 3D synovial organoid with T cells and RA-FLS alone. Simultaneous stimulation of T cells and RA-FLS together in co-culture was necessary for the formation of CD45RO+CD62L-CCR7-HLADR-CD25-CD69+CD49a+CD103+/- TRM cells. TNF stimulation of T cells or RA-FLS independently did not result in TRM cell formation. Transwell studies spatially separating the T cells from RA-FLS also abrogated TRM cell formation, demonstrating that cell contact is required during TNF stimulation to drive the differentiation process.

Conclusion: We show that TNF-driven TRM cell formation is mediated by FLS. Specifically, cell contact between T cells and RA-FLS is required at the time of TNF stimulation to drive the TRM cell differentiation process. Our data offer further insight into why TRM cells only form in arthritic joints and how inflammation plays an important role in the development of long-term joint-specific memory.


Disclosures: Y. Miyashita: None; Y. Yang: None; M. Mangin: None; M. Hahn: None; K. Wei: 10X Genomics, 5, Gilead sciences, 2, Merck/MSD, 5, Mestag, 2, santa ana bio, 2; P. Nigrovic: American Academy of Pediatrics, 9, Bristol-Myers Squibb(BMS), 5, Century Therapeutics, 2, Edelweiss Immuno, 8, Fresh Tracks Therapeutics, 2, Merck/MSD, 2, Monte Rosa Therapeutics, 2, Novartis, 2, Pfizer, 2, 5, Qiagen, 2, Sobi, 2, UpToDate, 9; M. Chang: None.

To cite this abstract in AMA style:

Miyashita Y, Yang Y, Mangin M, Hahn M, Wei K, Nigrovic P, Chang M. Synovial Resident Memory T Cell Formation During Inflammation Requires Cell Contact with Fibroblast-Like Synoviocytes [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/synovial-resident-memory-t-cell-formation-during-inflammation-requires-cell-contact-with-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-resident-memory-t-cell-formation-during-inflammation-requires-cell-contact-with-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology